OPPS final rule: CMS changes drug payment formula, physician supervision
Briefings on APCs, January 1, 2010
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.
CMS finalized a variation of its proposed new payment calculation for addressing hospital pharmacy overhead costs associated with separately payable drugs and biologicals.
However, the final result leaves hospitals with the same reimbursement rate for 2010 as hospitals have today for separately payable drugs—average sales price (ASP) plus 4%.
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- HIPAA Q&A: Level of encryption needed for email
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- QA:Coding multiple initial infusions
- OB services: Coding inside and outside of the package
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: Level of encryption needed for email
- CMS has reformulated payments for some bilateral procedures
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- What does case-mix index mean to you?
- Hospitals are not bound by InterQual criteria for determining patient status
- ED-to-inpatient transfers are flawed with safety gaps
- Searched
